Synthesis and Cyclooxygenase Enzyme Inhibitory Activity of Flurbiprofen Analogues: Simple Methodology of Their Nanoemulsion Systems

TAŞKOR ÖNEL G., SAYGILI N.

CHEMISTRYSELECT, vol.7, no.27, 2022 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 7 Issue: 27
  • Publication Date: 2022
  • Doi Number: 10.1002/slct.202201654
  • Journal Name: CHEMISTRYSELECT
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier
  • Keywords: Ibuprofen, Flurbiprofen, NSAIDs, Anti-inflammatory activity, Nanoemulsions, ANTIFUNGAL ACTIVITY, ANTIOXIDANT, INTRANASAL, NSAIDS, BRAIN, ACID
  • Hacettepe University Affiliated: Yes

Abstract

Most over-the-counter (OTC) and prescription NSAIDs have common side effects, especially gastrointestinal problems. Flurbiprofen, is an analogue of ibuprofen, that causes side effects and discomfort. This study was to synthesize flurbiprofen analogues, determine their NSAID activity using in vitro cyclooxygenase enzyme inhibitory assays and prepare their nanoemulsions. Six new flurbiprofen derivatives were synthesized via the reaction of acyl chloride (of flurbiprofen) and beta-amino alcohol, amino acid ester (or amino dicarboxylic acid ester). The masking of the free carboxylic acid functional group of flurbiprofen lowered the acidity by nearly two-fold. The compounds, tested for their cyclooxygenase (COX-1 and -2) enzyme inhibitory activity, showed analogues 3 d and 3 f could be of interest due to relatively higher COX-2 enzyme inhibition. Nanoemulsions (NEs) of flurbiprofen analogues (3 d and 3 f) were developed using high energy emulsification technique and the results showed that the optimized nanoemulsions of 3 d presented a droplet size of 225 nm, polydispersity index of 0.568, and zeta potential of +29.60 mV.